For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
As roles change, it’s worth keeping tabs on ‘prescribing diversity’
+Columns
As roles change, it’s worth keeping tabs on ‘prescribing diversity’
Monday 7 May 2018, 03:05 PM

Bill Douglas
Whanganui GP Bill Douglas questions whether more oversight is needed of prescribing patterns by different practitioners, from diverse backgrounds
The report in nzdoctor.co.nz on 3 May about a prescribing nurse practitioner who trained in Britain, spent some years working in a remote site in Gamb
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.